Zhulin Ma

448 total citations
16 papers, 321 citations indexed

About

Zhulin Ma is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Zhulin Ma has authored 16 papers receiving a total of 321 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Endocrinology, Diabetes and Metabolism, 8 papers in Surgery and 5 papers in Molecular Biology. Recurrent topics in Zhulin Ma's work include Pancreatic function and diabetes (8 papers), Diabetes Management and Research (7 papers) and Diabetes and associated disorders (5 papers). Zhulin Ma is often cited by papers focused on Pancreatic function and diabetes (8 papers), Diabetes Management and Research (7 papers) and Diabetes and associated disorders (5 papers). Zhulin Ma collaborates with scholars based in Denmark, China and Sweden. Zhulin Ma's co-authors include Anthony H. Cincotta, Richard E. Scranton, Michael Ezrokhi, Christopher M. O’Connor, J. Michael Gaziano, Dean Rutty, Jens Sandahl Christiansen, Torben Laursen, Tina Parkner and Guilian Zhang and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Diabetes Care and Life Sciences.

In The Last Decade

Zhulin Ma

16 papers receiving 308 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhulin Ma Denmark 8 218 96 77 56 42 16 321
Jin-dan Wu China 12 266 1.2× 101 1.1× 82 1.1× 30 0.5× 21 0.5× 29 372
Surya Panicker Rajeev United Kingdom 7 232 1.1× 107 1.1× 108 1.4× 49 0.9× 54 1.3× 14 285
Alena Welters Germany 9 154 0.7× 101 1.1× 72 0.9× 28 0.5× 13 0.3× 24 262
Katelee Barrett Mueller United States 5 270 1.2× 174 1.8× 84 1.1× 56 1.0× 45 1.1× 5 418
Anna Gasser Australia 6 125 0.6× 43 0.4× 68 0.9× 68 1.2× 11 0.3× 6 326
Makoto Shigeto Japan 7 202 0.9× 203 2.1× 127 1.6× 36 0.6× 22 0.5× 13 326
Chih-Hsun Chu Taiwan 12 183 0.8× 43 0.4× 45 0.6× 56 1.0× 23 0.5× 22 308
Ulrich Dischinger Germany 11 151 0.7× 155 1.6× 47 0.6× 80 1.4× 30 0.7× 49 346
R F James United Kingdom 10 193 0.9× 238 2.5× 96 1.2× 23 0.4× 27 0.6× 14 354
Imran J. Anwar United States 12 79 0.4× 167 1.7× 49 0.6× 47 0.8× 36 0.9× 33 360

Countries citing papers authored by Zhulin Ma

Since Specialization
Citations

This map shows the geographic impact of Zhulin Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhulin Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhulin Ma more than expected).

Fields of papers citing papers by Zhulin Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhulin Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhulin Ma. The network helps show where Zhulin Ma may publish in the future.

Co-authorship network of co-authors of Zhulin Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Zhulin Ma. A scholar is included among the top collaborators of Zhulin Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhulin Ma. Zhulin Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Chen, Ying, Zhulin Ma, Fei Liu, et al.. (2024). Is conduction system pacing more effective than right ventricular pacing in reducing atrial high-rate episodes in patients with heart failure and preserved ejection fraction?. Frontiers in Physiology. 15. 1500159–1500159. 1 indexed citations
2.
Ma, Zhulin, et al.. (2023). The feasibility and safety of his-purkinje conduction system pacing in patients with heart failure with severely reduced ejection fraction. Frontiers in Cardiovascular Medicine. 10. 1187169–1187169. 2 indexed citations
3.
Zhang, Lei, Yingying Guo, Heying Wang, et al.. (2019). Edaravone reduces Aβ-induced oxidative damage in SH-SY5Y cells by activating the Nrf2/ARE signaling pathway. Life Sciences. 221. 259–266. 29 indexed citations
4.
Emral, Rıfat, Faruque Pathan, Su‐Yen Goh, et al.. (2017). Self-reported hypoglycemia in insulin-treated patients with diabetes: Results from an international survey on 7289 patients from nine countries. Diabetes Research and Clinical Practice. 134. 17–28. 44 indexed citations
5.
Emral, Rıfat, Salah Abusnana, Su‐Yen Goh, et al.. (2016). Self-reported hypoglycemia in insulin-treated patients with diabetes: Results from an international survey of 7289 patients from 9 countries. Diabetes Research and Clinical Practice. 120. S113–S113. 1 indexed citations
6.
Pulkkinen, Mari‐Anne, et al.. (2015). Tissue IGF-I Measured by Microdialysis Reflects Body Glucose Utilization After rhIGF-I Injection in Type 1 Diabetes. The Journal of Clinical Endocrinology & Metabolism. 100(11). 4299–4306. 4 indexed citations
7.
Zhang, Guilian, Yaqi Li, Ru Zhang, et al.. (2015). Acute Submandibular Swelling Complicating Arteriography With Iodide Contrast. Medicine. 94(33). e1380–e1380. 14 indexed citations
8.
Zhang, Lei, et al.. (2015). Bilateral Medial Medullary Infarction with Nondominant Vertebral Artery Occlusion. Journal of Stroke and Cerebrovascular Diseases. 24(9). e241–e244. 7 indexed citations
9.
Zhang, Guilian, Yingying Guo, Lei Zhang, et al.. (2015). [The effect of edaravone on MAPKs signal pathway associated with Abeta(25-35) treatment in PC12 cells].. PubMed. 46(2). 179–84, 190. 2 indexed citations
10.
Ma, Zhulin, Jens Sandahl Christiansen, Torben Laursen, Torsten Lauritzen, & Jan Frystyk. (2014). Short-term effects of NPH insulin, insulin detemir, and insulin glargine on the GH–IGF1–IGFBP axis in patients with type 1 diabetes. European Journal of Endocrinology. 171(4). 471–479. 10 indexed citations
11.
Ma, Zhulin, et al.. (2014). Insulin aspart pharmacokinetics: An assessment of its variability and underlying mechanisms. European Journal of Pharmaceutical Sciences. 62. 65–75. 23 indexed citations
12.
Ma, Zhulin, Jens Sandahl Christiansen, Torben Laursen, et al.. (2014). Effects of human insulin and insulin aspart preparations on levels of IGF-I, IGFBPs and IGF bioactivity in patients with type 1 diabetes. BMC Endocrine Disorders. 14(1). 35–35. 5 indexed citations
13.
Ma, Zhulin, Jens Sandahl Christiansen, Torsten Lauritzen, et al.. (2013). Effects of human insulin and insulin aspart preparations on levels of IGFI, IGFBPs and IGFI bioactivity in patients with type 1 diabetes. Endocrine Abstracts. 2 indexed citations
14.
Ma, Zhulin, Tina Parkner, Jan Frystyk, et al.. (2012). A Comparison of Pharmacokinetics and Pharmacodynamics of Insulin Aspart, Biphasic Insulin Aspart 70, Biphasic Insulin Aspart 50, and Human Insulin: A Randomized, Quadruple Crossover Study. Diabetes Technology & Therapeutics. 14(7). 589–595. 11 indexed citations
15.
Ma, Zhulin, Tina Parkner, Jens Sandahl Christiansen, & Torben Laursen. (2012). IDegAsp: a novel soluble insulin analogs combination. Expert Opinion on Biological Therapy. 12(11). 1533–1540. 14 indexed citations
16.
Gaziano, J. Michael, Anthony H. Cincotta, Christopher M. O’Connor, et al.. (2010). Randomized Clinical Trial of Quick-Release Bromocriptine Among Patients With Type 2 Diabetes on Overall Safety and Cardiovascular Outcomes. Diabetes Care. 33(7). 1503–1508. 152 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026